1-(m-Chlorophenyl)piperazine (mCPP) interactions with neurotransmitter receptors in the human brain
- 1 March 1989
- journal article
- research article
- Published by Elsevier in Biological Psychiatry
- Vol. 25 (5), 569-575
- https://doi.org/10.1016/0006-3223(89)90217-5
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Identification of 5‐hydroxytryptamine1D binding sites in human brain membranesSynapse, 1989
- Identification and distribution of 5-HT3 receptors in rat brain using radioligand bindingNature, 1987
- Further studies on the blockade of 5-HT depolarizations of rabbit vagal afferent and sympathetic ganglion cells by MDL 72222 and other antagonistsNeuropharmacology, 1987
- Neuroendocrine and behavioral effects of m-chlorophenylpiperazine administration in rhesus monkeysLife Sciences, 1983
- Antagonism of vascular serotonin receptors by m-chlorophenylpiperazine and m-trifluoromethylphenylpiperazineLife Sciences, 1983
- Plasma concentrations of trazodone and 1-(3-chlorophenyl)piperazine in man after a single oral dose of trazodoneJournal of Pharmacy and Pharmacology, 1982
- Evidence that m-chlorophenylpiperazine inhibits some nociceptive responses of rats by activating 5-hydroxytryptamine mechanismsJournal of Pharmacy and Pharmacology, 1982
- Disposition and pharmacological effects of m-Chlorophenylpiperazine in ratsNeuropharmacology, 1981
- Effects of m-chlorophenylpiperazine on receptor binding and brain metabolism of monoamines in ratsNeurochemistry International, 1981
- l-(m-Chlorophenyl)piperazine: a metabolite of trazodone isolated from rat urineJournal of Pharmacy and Pharmacology, 1979